Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET

American Journal of Psychiatry

Volumn 159, Issue 8, 2002, Pages 1329-1336

  Singer, Harvey S ^a   Szymanski, Sally ^a   Giuliano, Joseph ^a   Yokoi, Fuji ^a   Dogan, A Semih ^a   Brasic, James R ^a   Zhou, Yun ^a   Grace, Anthony A ^a   Wong, Dean F ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; RACLOPRIDE; SODIUM CHLORIDE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SYNAPSE;

ADULT; AMPHETAMINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PUTAMEN; RACLOPRIDE; SODIUM CHLORIDE; SYNAPSES; TOMOGRAPHY, EMISSION-COMPUTED; TOURETTE SYNDROME;

EID: 0036334741     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.8.1329     Document Type: Article

References (54)

1. Tourette syndrome and other tic disorders: Diagnosis, pathophysiology, and treatment
2. Neurobiology of Tourette syndrome
3. Current issues in Tourette syndrome
4. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome
5. A functional neuroanatomy of tics in Tourette syndrome
6. Dopaminergic dysfunction in Tourette syndrome
7. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome
8. Biogenic amine metabolism in Tourette syndrome
9. Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration
10. Dopamine receptor availability in Tourette's syndrome
11. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette syndrome
12. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding
13. 2-like dopamine receptor density in Tourette syndrome measured by PET
14. 123I]β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
15. Dopamine transporter binding in Gilles de la Tourette syndrome
16. Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity
17. Dopamine transporter changes in neuropsychiatric disorders
18. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome
19. High presynaptic dopaminergic activity in children with Tourette's disorder
20. Quantification of extracellular dopamine release in schizophrenia and cocaine use by means of TREMBLE
21. 3H]raclopride binding in rat brain
22. Striatal binding of the PET ligand [11C]raclopride is altered by drugs that modify synaptic dopamine levels
23. 11C]raclopride in the human brain
24. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
25. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
26. 11C]raclopride at dopamine receptors in human subjects
27. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT
28. Definitions and classification of tic disorders
29. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity
30. The validity of instruments measuring tic severity in Tourette syndrome
31. MRI-PET correlation in three dimensions using a volume-of-interest (VOI) atlas
32. Column-switching HPLC for the analysis of plasma in PET imaging studies
33. True equilibrium bolus estimation (TREMBLE) confirms rapid transient equilibrium
34. 2-like dopamine receptors: Theory, validation and changes during normal aging
35. Imaging synaptic neurotransmission with in-vivo binding competition techniques: A critical review
36. 11C]raclopride and PET in normal human subjects
37. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
38. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
39. Dopamine transporter density in patients with attention deficit hyperactivity disorder
40. Course of tic severity in Tourette syndrome: The first two decades
41. Adult tics in Gilles de la Tourette's syndrome: Descriptions and risk factors
42. Infection: A stimulus for tic disorders
43. Volumetric MRI changes in basal ganglia of children with Tourette's syndrome
44. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images
45. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release
46. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways
47. 2-adrenergic control of dopamine overflow and metabolism in mouse striatum
48. 2Aadrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices
49. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia
50. Imaging intrasynaptic, postsynaptic and presynaptic dopamine dysfunction in psychosis
51. Brain monoamines and amino acids in Gilles de la Tourette's syndrome: A preliminary study of subcortical regions
52. Gilles de la Tourette's syndrome: Effects of stimulant drugs
53. Gilles de la Tourette syndrome: Tics and central nervous system stimulants in twins and nontwins
54. Serum haloperidol levels in Gilles de la Tourette syndrome